Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Marc A. Suchard, Clair Blacketer et al.|BMJ Medicine|2023Cited by 27
ZmGDIα-hel counters the RBSDV-induced reduction of active gibberellins to alleviate maize rough dwarf virus diseaseSuining Deng, Mingliang Xu, Qingcai Liu et al.|Nature Communications|2024Cited by 10